Autonomix Medical, Inc.
AMIX
$1.30
-$0.07-5.11%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 6.66M | 6.78M | 7.42M | 6.55M | 5.25M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 200.00K | 100.00K | -- | -- | -- |
Total Operating Expenses | 11.59M | 10.75M | 10.93M | 9.36M | 7.48M |
Operating Income | -11.59M | -10.75M | -10.93M | -9.36M | -7.48M |
Income Before Tax | -11.41M | -13.63M | -14.03M | -17.26M | -15.43M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -11.41 | -13.63 | -14.03 | -17.26 | -15.43 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -11.41M | -13.63M | -14.03M | -17.26M | -15.43M |
EBIT | -11.59M | -10.75M | -10.93M | -9.36M | -7.48M |
EBITDA | -11.41M | -10.57M | -10.78M | -7.99M | -5.28M |
EPS Basic | -7.95 | -11.44 | -13.04 | -19.36 | -17.84 |
Normalized Basic EPS | -4.97 | -7.15 | -8.15 | -12.10 | -11.15 |
EPS Diluted | -7.95 | -11.44 | -13.04 | -19.36 | -17.84 |
Normalized Diluted EPS | -4.97 | -7.15 | -8.15 | -12.10 | -11.15 |
Average Basic Shares Outstanding | 6.69M | 5.10M | 4.26M | 3.81M | 3.51M |
Average Diluted Shares Outstanding | 6.69M | 5.10M | 4.26M | 3.81M | 3.51M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |